Therefore, they act as tumor suppressor genes, as mutations have been observed in tumor cells due to genomic instability, and approximately 80% of BRCA1 and 3–17% of BRCA2-related BC belong to the TNBC subtype [5]. The gene discussed is BRCA2; the disease is neoplasm.